Star Health and Allied Insurance (STARHEALTH) Stock Overview
Provides health insurance products in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for STARHEALTH from our risk checks.
STARHEALTH Community Fair Values
Create NarrativeSee what 22 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Star Health and Allied Insurance Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹519.60 |
| 52 Week High | ₹586.25 |
| 52 Week Low | ₹412.60 |
| Beta | 0.22 |
| 1 Month Change | 2.49% |
| 3 Month Change | 12.08% |
| 1 Year Change | 17.11% |
| 3 Year Change | -2.05% |
| 5 Year Change | n/a |
| Change since IPO | -42.70% |
Recent News & Updates
Narrative Update • Jun 12
STARHEALTH: Upcoming Governance Decisions Will Support A Constructive Long Term Outlook
Analysts have kept their price target for Star Health and Allied Insurance steady at ₹580.70, reflecting unchanged assumptions on fair value, discount rate, revenue, profit margin, and future P/E. What's in the News Board meeting scheduled for April 28, 2026, at 11:30 Indian Standard Time to consider and approve the standalone audited financial results for the year ended March 31, 2026, and to review a declaration on the audit report with unmodified opinion in line with regulatory requirements.Narrative Update • May 29
STARHEALTH: Upcoming Board And Shareholder Meetings Will Support Steady Outlook
Analysts now see fair value for Star Health and Allied Insurance at around ₹580.70, up from about ₹528.14, citing slightly adjusted assumptions for discount rate, revenue growth, profit margin, and future P/E. What's in the News Board meeting scheduled for April 28, 2026 at 11:30 Indian Standard Time to consider and approve standalone audited financial results for the year ended March 31, 2026, along with related audit report declarations and other matters (company filing).Narrative Update • Apr 23
STARHEALTH: Upcoming Board Meeting And Results Will Support Steady Fair Valuation Outlook
Analysts have nudged their fair value estimate for Star Health and Allied Insurance slightly higher, with the price target moving from ₹527.68 to ₹528.14 as they fine tune assumptions for revenue growth, profit margin, and future P/E expectations. What's in the News A board meeting is scheduled for Apr 28, 2026, to consider and approve standalone audited financial results for the year ended Mar 31, 2026 (company filing).Narrative Update • Apr 09
STARHEALTH: Upcoming Results And Board Meeting Will Support Steady Earnings Outlook
Analysts have slightly reduced their price target for Star Health and Allied Insurance from ₹530.41 to ₹527.68. This adjustment reflects updated assumptions around revenue growth, profit margin, and future P/E expectations.Recent updates
Narrative Update • Jun 12
STARHEALTH: Upcoming Governance Decisions Will Support A Constructive Long Term Outlook
Analysts have kept their price target for Star Health and Allied Insurance steady at ₹580.70, reflecting unchanged assumptions on fair value, discount rate, revenue, profit margin, and future P/E. What's in the News Board meeting scheduled for April 28, 2026, at 11:30 Indian Standard Time to consider and approve the standalone audited financial results for the year ended March 31, 2026, and to review a declaration on the audit report with unmodified opinion in line with regulatory requirements.Narrative Update • May 29
STARHEALTH: Upcoming Board And Shareholder Meetings Will Support Steady Outlook
Analysts now see fair value for Star Health and Allied Insurance at around ₹580.70, up from about ₹528.14, citing slightly adjusted assumptions for discount rate, revenue growth, profit margin, and future P/E. What's in the News Board meeting scheduled for April 28, 2026 at 11:30 Indian Standard Time to consider and approve standalone audited financial results for the year ended March 31, 2026, along with related audit report declarations and other matters (company filing).Narrative Update • Apr 23
STARHEALTH: Upcoming Board Meeting And Results Will Support Steady Fair Valuation Outlook
Analysts have nudged their fair value estimate for Star Health and Allied Insurance slightly higher, with the price target moving from ₹527.68 to ₹528.14 as they fine tune assumptions for revenue growth, profit margin, and future P/E expectations. What's in the News A board meeting is scheduled for Apr 28, 2026, to consider and approve standalone audited financial results for the year ended Mar 31, 2026 (company filing).Narrative Update • Apr 09
STARHEALTH: Upcoming Results And Board Meeting Will Support Steady Earnings Outlook
Analysts have slightly reduced their price target for Star Health and Allied Insurance from ₹530.41 to ₹527.68. This adjustment reflects updated assumptions around revenue growth, profit margin, and future P/E expectations.Narrative Update • Mar 25
STARHEALTH: Upcoming Results Will Support Confidence In Steady Earnings Outlook
Analysts have kept their fair value estimate for Star Health and Allied Insurance steady at about ₹530, reflecting largely unchanged assumptions on revenue growth, profit margin and future P/E. As a result, the latest price target update is more of a fine tune than a reset for your expectations.Narrative Update • Mar 09
STARHEALTH: Upcoming Results Date Will Reinforce Confidence In Earnings Outlook
Analysts have nudged their fair value estimate for Star Health and Allied Insurance slightly higher, lifting the price target from ₹525.41 to ₹530.41. This reflects fine tuned assumptions around revenue growth, profit margins and future P/E expectations.Narrative Update • Feb 22
STARHEALTH: Steady Assumptions And Upcoming Results Will Support Further Upside
Analysts have kept their price target for Star Health and Allied Insurance steady at around ₹525, reflecting unchanged assumptions on discount rate, revenue growth, profit margin and future P/E. This indicates that their fundamental view on the stock is currently consistent with prior expectations.Analysis Article • Feb 16
Star Health and Allied Insurance Company Limited (NSE:STARHEALTH) Not Flying Under The Radar
Star Health and Allied Insurance Company Limited's ( NSE:STARHEALTH ) price-to-earnings (or "P/E") ratio of 61.7x might...Narrative Update • Feb 08
STARHEALTH: Upcoming Board Meeting And Stable Margins Will Support Further Upside
Analysts have lifted their fair value estimate for Star Health and Allied Insurance from ₹515.82 to ₹525.41, citing updated assumptions around the discount rate, revenue growth, profit margin and future P/E that adjust their overall outlook on the stock. What's in the News Board meeting scheduled on January 28, 2026 to consider and approve standalone unaudited financial results for the quarter and nine months ended December 31, 2025 (Key Developments).Narrative Update • Jan 24
STARHEALTH: Stable Margins And Upcoming Results Will Support Further Upside
Analysts have nudged their fair value estimate for Star Health and Allied Insurance slightly lower, from ₹516.05 to ₹515.82 per share, as small adjustments in revenue growth, profit margin assumptions, and future P/E expectations offset each other in their updated models. What's in the News Board meeting scheduled on Jan 28, 2026 to consider and approve standalone unaudited financial results for the quarter and nine months ended Dec 31, 2025 (Key Developments).Narrative Update • Jan 09
STARHEALTH: Higher Fair Value And Solid Margins Will Support Upside Potential
Analysts have inched up their fair value estimate for Star Health and Allied Insurance to ₹516.05 from ₹512.23, reflecting small tweaks to revenue growth, profit margin and future P/E assumptions. What's in the News Board meeting scheduled for Jan 28, 2026, to consider and approve standalone unaudited financial results for the quarter and nine months ended Dec 31, 2025 (company filing).Narrative Update • Dec 14
STARHEALTH: Steady Earnings Outlook Will Support A Balanced Near-Term View
Analysts have nudged their fair value estimate for Star Health and Allied Insurance slightly higher to ₹512 from about ₹511, reflecting steady expectations for revenue growth, profit margins, and future earnings multiples despite only marginal model adjustments. What's in the News Board meeting scheduled on October 28, 2025, to review and approve standalone unaudited financial results for the quarter and half year ended September 30, 2025, along with other business matters (company filing) Special or extraordinary shareholders meeting to be conducted via postal ballot in India on December 20, 2025, indicating upcoming shareholder decisions on key corporate matters (company filing) Valuation Changes The fair value estimate has risen slightly to about ₹512.23 from ₹511.32, reflecting a marginally more optimistic assessment of intrinsic value.Narrative Update • Nov 29
STARHEALTH: Digital Momentum And Product Clarity Will Support A Balanced Near-Term Outlook
Analysts have raised their price target for Star Health and Allied Insurance slightly from ₹508.14 to ₹511.32, citing improved revenue growth projections as the key driver for this upward adjustment. What's in the News Star Health and Allied Insurance Company Limited will hold a Special/Extraordinary Shareholders Meeting on December 20, 2025, via postal ballot in India (Key Developments).Narrative Update • Nov 15
STARHEALTH: Digital Adoption Progress And Balanced Outlook Will Shape Future Performance
Narrative Update: Star Health and Allied Insurance Analyst Price Target Revision Analysts have raised their fair value estimate for Star Health and Allied Insurance from ₹495.59 to ₹508.14. This change reflects slightly improved long-term projections, even though there is some moderation in near-term revenue growth and profit margin expectations.Analysis Article • Nov 02
Analysts Are Updating Their Star Health and Allied Insurance Company Limited (NSE:STARHEALTH) Estimates After Its Second-Quarter Results
Last week saw the newest second-quarter earnings release from Star Health and Allied Insurance Company Limited...Narrative Update • Oct 31
STARHEALTH: Automation And Digital Expansion Will Drive Customer Experience Forward
Narrative Update: Star Health and Allied Insurance Price Target Revised Upwards Analysts have raised their price target for Star Health and Allied Insurance from ₹478.32 to ₹495.59, citing improved revenue growth projections and higher expected profit margins. What's in the News A board meeting is scheduled for October 28, 2025, to consider and approve the standalone un-audited financial results for the quarter and half year ended September 30, 2025, along with other related business matters (Key Developments).Narrative Update • Oct 17
Digital Distribution And Risk Pricing Will Shape Indian Health Insurance
Narrative Update: Star Health and Allied Insurance Analyst Price Target Revision Analysts have raised their price target for Star Health and Allied Insurance from ₹469.23 to ₹478.32, reflecting a marginally improved profit margin outlook, even as revenue growth assumptions are slightly softer. What's in the News Board meeting scheduled on October 28, 2025 to consider and approve unaudited financial results for the quarter and half-year ended September 30, 2025, along with other business matters (Key Developments).Analysis Article • Sep 30
Investors Appear Satisfied With Star Health and Allied Insurance Company Limited's (NSE:STARHEALTH) Prospects
With a price-to-earnings (or "P/E") ratio of 43.7x Star Health and Allied Insurance Company Limited ( NSE:STARHEALTH...Analysis Article • Aug 03
Earnings Miss: Star Health and Allied Insurance Company Limited Missed EPS By 14% And Analysts Are Revising Their Forecasts
Star Health and Allied Insurance Company Limited ( NSE:STARHEALTH ) missed earnings with its latest first-quarter...Analysis Article • Jun 02
Market Participants Recognise Star Health and Allied Insurance Company Limited's (NSE:STARHEALTH) Earnings Pushing Shares 27% Higher
Star Health and Allied Insurance Company Limited ( NSE:STARHEALTH ) shareholders have had their patience rewarded with...Analysis Article • May 02
Star Health and Allied Insurance Company Limited Just Missed EPS By 15%: Here's What Analysts Think Will Happen Next
As you might know, Star Health and Allied Insurance Company Limited ( NSE:STARHEALTH ) last week released its latest...Analysis Article • Apr 08
Star Health and Allied Insurance Company Limited's (NSE:STARHEALTH) Share Price Not Quite Adding Up
There wouldn't be many who think Star Health and Allied Insurance Company Limited's ( NSE:STARHEALTH...
New Narrative • Dec 28
Superstar Plan And Digital Expansion Set To Drive Revenue Growth And Boost Profitability
Innovative insurance products and digital expansion are set to drive revenue growth and enhance customer engagement, lowering acquisition costs.Analysis Article • Dec 23
Investors Interested In Star Health and Allied Insurance Company Limited's (NSE:STARHEALTH) Earnings
With a median price-to-earnings (or "P/E") ratio of close to 32x in India, you could be forgiven for feeling...Analysis Article • Jun 12
Here's Why We Think Star Health and Allied Insurance (NSE:STARHEALTH) Is Well Worth Watching
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...Analysis Article • Apr 25
Star Health and Allied Insurance Company Limited's (NSE:STARHEALTH) Business Is Yet to Catch Up With Its Share Price
With a price-to-earnings (or "P/E") ratio of 41.5x Star Health and Allied Insurance Company Limited ( NSE:STARHEALTH...Analysis Article • Jun 09
Star Health and Allied Insurance Company Limited's (NSE:STARHEALTH) Price In Tune With Revenues
When close to half the companies in the Insurance industry in India have price-to-sales ratios (or "P/S") below 1.5x...Shareholder Returns
| STARHEALTH | IN Insurance | IN Market | |
|---|---|---|---|
| 7D | -1.2% | -1.6% | 0.05% |
| 1Y | 17.1% | -13.3% | -2.0% |
Return vs Industry: STARHEALTH exceeded the Indian Insurance industry which returned -13.3% over the past year.
Return vs Market: STARHEALTH exceeded the Indian Market which returned -2% over the past year.
Price Volatility
| STARHEALTH volatility | |
|---|---|
| STARHEALTH Average Weekly Movement | 2.9% |
| Insurance Industry Average Movement | 4.3% |
| Market Average Movement | 7.1% |
| 10% most volatile stocks in IN Market | 10.2% |
| 10% least volatile stocks in IN Market | 4.7% |
Stable Share Price: STARHEALTH has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: STARHEALTH's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 14,585 | Anand Roy | www.starhealth.in |
Star Health and Allied Insurance Company Limited provides health insurance products in India. It offers retail health insurance products for individuals, families, children, senior citizens, and persons with pre-existing medical conditions; group health insurance products for employer/employee and non-employer/employee groups, including small-to-medium enterprises; and personal accident and travel insurance products. The company also provides star women care insurance policy that provides surrogacy and oocyte donor covers; and star special care product that covers children diagnosed with autism and for outpatient specialized treatments.
Star Health and Allied Insurance Company Limited Fundamentals Summary
| STARHEALTH fundamental statistics | |
|---|---|
| Market cap | ₹305.50b |
| Earnings (TTM) | ₹5.57b |
| Revenue (TTM) | ₹178.33b |
54.8x
P/E Ratio1.7x
P/S RatioIs STARHEALTH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| STARHEALTH income statement (TTM) | |
|---|---|
| Revenue | ₹178.33b |
| Cost of Revenue | ₹140.48b |
| Gross Profit | ₹37.85b |
| Other Expenses | ₹32.28b |
| Earnings | ₹5.57b |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 9.47 |
| Gross Margin | 21.22% |
| Net Profit Margin | 3.12% |
| Debt/Equity Ratio | 6.2% |
How did STARHEALTH perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/13 03:13 |
| End of Day Share Price | 2026/06/12 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2026/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Star Health and Allied Insurance Company Limited is covered by 29 analysts. 21 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Swarnabha Mukherjee | 360 ONE Capital Market Private Limited |
| Ashwin Mehta | Ambit Capital |
| Raghav Garg | Ambit Capital |